Study of TQF3250 capsules for type 2 diabetes with overweight or obesity
Part of Hormones & metabolism clinical trials.
This study tests a new capsule medicine for adults with type 2 diabetes who are overweight or have obesity. The goal is to see if it helps control blood sugar and weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to provide signed consent and be willing to follow the study plan, including diet and exercise.
- You must be 18 to 70 years old.
- You must be diagnosed with type 2 diabetes and also have overweight or obesity.
- You must not have other types of diabetes or complications from diabetes that need urgent care.
- You haven't had uncontrolled heart, liver, kidney, or other serious health problems recently.
- Women who can get pregnant and men must agree to use effective birth control during the trial and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental capsule that may help with weight loss. It is for people who are overweight or obese and have not been able to lose weight with lifestyle changes alone.
This trial tests a new oral medication (TQF3250) in healthy adults to see how safe it is and how the body processes it. If you are a generally healthy Chinese volunteer, you may be able to help researchers learn about this potential treatment.
This study tests two investigational medications, MET233 and MET097, in people with obesity or overweight, with or without type 2 diabetes. It aims to see if the combination can help with weight loss and blood sugar control.
This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.
This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.
This study tests an oral medication called VK2735 for weight management in adults with type 2 diabetes. The goal is to see if it helps with weight loss and blood sugar control.
Hear when a new Type 2 Diabetes Mellitus Combined With Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.